2-[[(Ethoxy)(phthalimidomethyl)phosphinyl]methyl]-4-methylvaleric acid → (2-Oxoazacyclotridecan-3-yl)valeramide

HRID 476715Notes

Reaction equation

HRID 476715 reaction equation
C(OP(CC(CC(C)C)C(O)=O)(C[N:7]1[C:11](=[O:12])[C:10]2=CC=[CH:15][CH:16]=[C:9]2C1=O)=O)C.N[CH:28]1[CH2:40][CH2:39][CH2:38][CH2:37][CH2:36][CH2:35][CH2:34][CH2:33][CH2:32][CH2:31][C:30](=[O:41])[NH:29]1>>[O:41]=[C:30]1[CH:31]([CH:10]([CH2:9][CH2:16][CH3:15])[C:11]([NH2:7])=[O:12])[CH2:32][CH2:33][CH2:34][CH2:35][CH2:36][CH2:37][CH2:38][CH2:39][CH2:40][CH2:28][NH:29]1

Participants

3

Procedure

In a manner analogous to that described in Example 1(A)(iv), from 1.9 g of 2(RS)-[[(RS)-(ethoxy)(phthalimidomethyl)phosphinyl]methyl]-4-methylvaleric acid and 1.0 g of (-)-3-amino-2-azacyclotridecanone, there were obtained 2.1 g of 2(RS)-[[(RS)-(ethoxy)(phthalimidomethyl)phosphinyl]methyl]-4-methyl-N(R or S)-(2-oxoazacyclotridecan-3-yl)valeramide in the form of a white solid.

Sources & evidence

ORD record
ord-f90d9282a2e64dde8c32f325e1801731
Source dataset
uspto-grants-1989_12
Patent number
US04885283

Reaction notes

Loading…